Advertisement

Topics

CymaBay Following The Leaders, Pursues NASH, PBC Simultaneously

14:06 EDT 16 Apr 2019 | SCRIP

Biotech thinks its PPAR delta agonist will prove much more potent than Genfit’s elafibranor from the same class and will...

      

Related Stories

 

Original Article: CymaBay Following The Leaders, Pursues NASH, PBC Simultaneously

NEXT ARTICLE

More From BioPortfolio on "CymaBay Following The Leaders, Pursues NASH, PBC Simultaneously"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...